About Index Trending news
Analyze
Pricing
Kineta, Inc

Kineta, Inc

Work at Kineta, Inc? Add yourself to this profile

Kineta, Inc

Kineta is a nationally-recognized biotechnology company developing novel autoimmune, antiviral and chronic pain therapeutics

Elsewhere

Alexa global traffic share

Twitter followers

26 Jul 2016
Undisclosed funding
Added by

This Seattle biotech startup just secured funding to tackle the Zika virus

GeekWire
21 Jul 2016
$1,500,000
Grant
The Wellcome Trust

Kineta Secures NIAID Funding to Expand Testing of Immune Modulators

yahoo
+2
25 May 2016
$760,780
Venture capital

SEC FORM D/A

sec
29 Jul 2015
$4,000,000
Grant
National Institute of Allergy and Infectious Diseases
Added by

Kineta wins $4M award to develop therapies against viral diseases like Ebola, influenza, others

GeekWire